ABT-737 ≥95%
Supplier: ADIPOGEN CORP MS
|
Warning
|
ABT-737 is a small-molecule inhibitor of the anti-apoptotic proteins Bcl-2, Bcl-X(L) and Bcl-w, with an affinity two to three orders of magnitude more potent than previously reported compounds. Mechanistic studies reveal that ABT-737 does not directly initiate the apoptotic process, but enhances the effects of death signals, displaying synergistic cytotoxicity with chemotherapeutics and radiation. ABT-737 exhibits single-agent-mechanism-based killing of cells from lymphoma and small-cell lung carcinoma lines, as well as primary patient-derived cells, and in animal models, ABT-737 improves survival, causes regression of established tumors, and produces cures in a high percentage of the mice. ABT-737 binds to Bcl-2, Bcl-xL and Bcl-w with very high affinities (Ki
Formula:
C₄₂H₄₅ClN₆O₅S₂ Storage Temperature: Freezer |
MDL Number:
MFCD12756212 CAS Number: 852808-04-9 |
Specification Test Results
Purity |
|
Appearance/Color | Solid. |
Solubility |
Soluble in DMSO. Slightly soluble ( |
Learn more
About VWR
Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...